The EU-funded AI-Mind project has launched a survey regarding the current clinical practices related to the diagnosis of mild cognitive impairment (MCI) and the needs for diagnostic tools to predict, at an early stage, who is likely to develop dementia. The purpose of this survey is to capture information related to existing clinical guidelines, reimbursement schemes and challenges, as well as to identify the state-of-the-art tools used in European hospitals for screening, diagnosing, monitoring and collecting information on met and unmet needs for the early diagnosis of people with MCI.
The survey is opened to all healthcare professionals (e.g. clinicians, nurses, psychologists) working in the field of dementia and MCI across all European countries. The survey is available online and planned to run until 1 August. If you are interested in taking part, please click here: https://nettskjema.no/a/aimindsurvey. If you have any questions, please contact contact@ai-mind.eu
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 964220.
